This study evaluates the effect of Intraocular Phenylephrine/Ketorolac Infusion on Retinal Thickness and Macular Edema in Cataract Surgery. Participants will receive infusions of Phenylephrine/Ketorolac during surgery instead of receiving topical NSAID drops pre and post operatively.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Best Corrected Visual Acuity (BCVA) (Pre-op)
Timeframe: Baseline
Best Corrected Visual Acuity (BCVA) (Week 2)
Timeframe: 2 weeks
Best Corrected Visual Acuity (BCVA) (Week 6)
Timeframe: 6 weeks
Number of Participants That Develop Presence of Cystoid Macular Edema (CME)
Timeframe: 2 weeks
Change From Baseline in Macular Thickness Measurement - Number in Microns
Timeframe: Baseline and week 6
Number of Participants Needing NSAID Post-operatively
Timeframe: Post-op weeks 1 through 6
Change in Anterior Chamber Cells From Baseline Measurement
Timeframe: Week 6